AGP Picks
View all

Colorado Health Reporter
Provided by AGP

Colorado Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Colorado Health Reporter.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on May 15, 2026

Oncotelic Therapeutics Files First Quarter 2026 Financial Results and Strategic Progress
May 15, 2026

Oncotelic Therapeutics Files First Quarter 2026 Financial Results and Strategic Progress

Indeterminate GlobeNewswire
Propanc Biopharma Provides Corporate Update and Reports Third Quarter 2025/26 Results
May 15, 2026

Propanc Biopharma Provides Corporate Update and Reports Third Quarter 2025/26 Results

Indeterminate GlobeNewswire
Clearmind Medicine CEO Dr. Adi Zuloff-Shani named Delegate to Federal Policy Summit on Psychedelic Medicine in Washington, D.C.
May 15, 2026

Clearmind Medicine CEO Dr. Adi Zuloff-Shani named Delegate to Federal Policy Summit on Psychedelic Medicine in Washington, D.C.

Indeterminate GlobeNewswire
SRx Health Solutions Announces Board Approval to Dividend 75% of Profits from Investment in Astro Investment XVII, an Affiliate of Astro Capital and SPV with Investments in SpaceX and Other Artificial Intelligence and Space Companies
May 15, 2026

SRx Health Solutions Announces Board Approval to Dividend 75% of Profits from Investment in Astro Investment XVII, an Affiliate of Astro Capital and SPV with Investments in SpaceX and Other Artificial Intelligence and Space Companies

Indeterminate GlobeNewswire
Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025
May 15, 2026

Jyong Biotech Ltd. Files Annual Report on Form 20-F for Fiscal Year 2025

Indeterminate GlobeNewswire
Silexion Therapeutics Announces Exercise of Warrants for $1 Million Gross Proceeds
May 15, 2026

Silexion Therapeutics Announces Exercise of Warrants for $1 Million Gross Proceeds

Indeterminate GlobeNewswire
Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting
May 15, 2026

Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting

Indeterminate GlobeNewswire
Galectin Therapeutics Reports March 31, 2026 Financial Results and Provides Business Update
May 15, 2026

Galectin Therapeutics Reports March 31, 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform
May 15, 2026

INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform

Indeterminate GlobeNewswire
CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients
May 15, 2026

CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients

Indeterminate GlobeNewswire
aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update
May 15, 2026

aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update

Indeterminate GlobeNewswire
Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results
May 15, 2026

Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
UroGen Reports 94.5% Six-Month Duration of Response in Phase 3 UTOPIA Trial, Advancing UGN-103 Toward Potential Approval in Recurrent Low-Grade Intermediate-Risk NMIBC
May 15, 2026

UroGen Reports 94.5% Six-Month Duration of Response in Phase 3 UTOPIA Trial, Advancing UGN-103 Toward Potential Approval in Recurrent Low-Grade Intermediate-Risk NMIBC

Indeterminate GlobeNewswire
GT Biopharma Reports First Quarter 2026 Financial Results
May 15, 2026

GT Biopharma Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™
May 15, 2026

BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™

Indeterminate GlobeNewswire
MiNK Therapeutics Reports First Quarter 2026 Financial Results and Advances iNKT Cell Therapy Platform Into Randomized Clinical Validation
May 15, 2026

MiNK Therapeutics Reports First Quarter 2026 Financial Results and Advances iNKT Cell Therapy Platform Into Randomized Clinical Validation

Indeterminate GlobeNewswire
Palvella Therapeutics Announces New Data from the Phase 2 TOIVA Trial of QTORIN™ Rapamycin in Cutaneous Venous Malformations Presented at the 83rd Annual Meeting of the Society for Investigative Dermatology
May 15, 2026

Palvella Therapeutics Announces New Data from the Phase 2 TOIVA Trial of QTORIN™ Rapamycin in Cutaneous Venous Malformations Presented at the 83rd Annual Meeting of the Society for Investigative Dermatology

Indeterminate GlobeNewswire
Annovis Provides Corporate Updates and Reports First Quarter 2026 Financial Results
May 15, 2026

Annovis Provides Corporate Updates and Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Profusa Announces Listing Transfer to The Nasdaq Capital Market
May 15, 2026

Profusa Announces Listing Transfer to The Nasdaq Capital Market

Indeterminate GlobeNewswire
Davos Alzheimer’s Collaborative Celebrates Andrea Pfeifer, Retiring CEO of AC Immune, for Her Contributions to Alzheimer’s Policy, Research and Care
May 15, 2026

Davos Alzheimer’s Collaborative Celebrates Andrea Pfeifer, Retiring CEO of AC Immune, for Her Contributions to Alzheimer’s Policy, Research and Care

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Colorado Health Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.